Trials / Unknown
UnknownNCT01693328
Patient Satisfaction and Quality of Life Impact - PecFent®
A French, Multicentre, Open-label, Observational Study to Assess Quality of Life and Satisfaction in Subjects Taking PecFent® for the Treatment of Breakthrough Cancer Pain (BTPc)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (estimated)
- Sponsor
- Archimedes Development Ltd · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
National multicenter, prospective, observational study in cancer patients with chronic background pain and breakthrough pain to whom PecFent® has been prescribed under pragmatic condition by a specialist in the treatment of cancer pain conditions. • Study objectives include assessment of early treatment satisfaction.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PecFent® (fentanyl) nasal spray |
Timeline
- Start date
- 2012-09-01
- Primary completion
- 2014-03-01
- First posted
- 2012-09-26
- Last updated
- 2014-01-15
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01693328. Inclusion in this directory is not an endorsement.